Evidence map›Paper›PMID 40367226›Full record

ArticlePloS one2025

Segmentation-based lightweight multi-class classification model for crop disease detection, classification, and severity assessment using DCNN.

Chatla Subbarayudu, Mohan Kubendiran

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chatla SubbarayuduSchool of Computer Science and Engineering, Vellore Institute of Technology, Vellore, India.ORCID https://orcid.org/0000-0001-9943-7402
Mohan KubendiranSchool of Computer Science and Engineering, Vellore Institute of Technology, Vellore, India.ORCID https://orcid.org/0000-0001-5736-8525

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leaf diseases in Zea mays crops have a significant impact on both the calibre and volume of maize yield, eventually impacting the market. Prior detection of the intensity of an infection would enable the efficient allocation of treatment resources and prevent the infection from spreading across the entire area. In this study, deep saliency map segmentation-based CNN is utilized for the detection, multi-class classification, and severity assessment of maize crop leaf diseases has been proposed. The proposed model involves seven different maize crop diseases such as Northern Leaf Blight Exserohilum turcicum, Eye Spot Oculimacula yallundae, Common Rust Puccinia sorghi, Goss's Bacterial Wilt Clavibacter michiganensis subsp. nebraskensis, Downy Mildew Pseudoperonospora, Phaeosphaeria leaf spot Phaeosphaeria maydis, Gray Leaf Spot Cercospora zeae-maydis, and Healthy are selected from publicly available datasets obtained from PlantVillage. After the disease-affected regions are identified, the features are extracted by using the EffiecientNet-B7. To classify the maize infection, a hybrid harris hawks' optimization (HHHO) is utilized for feature selection. Finally, from the optimized features obtained, classification and severity assessment are carried out with the help of Fuzzy SVM. Experimental analysis has been carried out to demonstrate the effectiveness of the proposed approach in detecting maize crop leaf diseases and assessing their severity. The proposed strategy was able to obtain an accuracy rate of around 99.47% on average. The work contributes to advancing automated disease diagnosis in agriculture, thereby supporting efforts for sustainable crop yield improvement and food security.

Indexed as

Crops, AgriculturalNeural Networks, ComputerPlant DiseasesZea maysPlant Leaves

Identifiers

PMID40367226
PMCPMC12077804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.